Urogenital cancers, which include prostate, bladder, and kidney malignancies, exert a substantial impact on global cancer-related morbidity and mortality. Proteomic biomarkers, emerging as valuable tools, aim to enhance early detection, prognostic accuracy, and the development of personalized therapeutic strategies. This study undertook a comprehensive systematic review and meta-analysis of the existing literature investigating the role and potential of proteomic biomarkers in plasma, tissue, and urine samples in urogenital cancers. Our extensive search across several databases identified 1879 differentially expressed proteins from 37 studies, signifying their potential as unique biomarkers for these cancers. A meta-analysis of the significantly differentially expressed proteins was executed, accentuating the findings through visually intuitive volcano plots. A functional enrichment analysis unveiled their significant involvement in diverse biological processes, including signal transduction, immune response, cell communication, and cell growth. A pathway analysis highlighted the participation of key pathways such as the nectin adhesion pathway, TRAIL signaling pathway, and integrin signaling pathways. These findings not only pave the way for future investigations into early detection and targeted therapeutic approaches but also underscore the fundamental role of proteomics in advancing our understanding of the molecular mechanisms underpinning urogenital cancer pathogenesis. Ultimately, these findings hold remarkable potential to significantly enhance patient care and improve clinical outcomes.
Breast cancer continues to be the most frequently diagnosed cancer among women worldwide and remains a leading cause of cancer-related mortality. Despite advances in imaging and biopsy-based approaches, current diagnostic methods are invasive, costly, and often insufficient to capture the molecular heterogeneity of tumors. Extracellular vesicles (EVs) have emerged as promising non-invasive biomarkers owing to their role in intercellular communication and their enrichment with tumor-specific cargo. This study conducted a systematic review and meta-analysis of published literature to investigate proteomic alterations in EVs derived from breast cancer samples. From an initial 1097 records screened, four eligible studies were identified, reporting 628 differentially expressed proteins, of which 38 were consistently observed across multiple datasets. Functional enrichment analyses revealed predominant localization of these proteins to vesicle-associated compartments and significant involvement in biological processes related to cell growth, immune regulation, and tumor progression. Pathway analysis further highlighted integrin-mediated interactions, platelet activation, and hemostasis pathways as key molecular mechanisms represented within breast cancer EVs. Overall, the findings reveal a distinct EV proteomic signature in breast cancer that could support early detection and patient monitoring through minimally invasive testing. Future large-scale and standardized studies are needed to validate these candidate proteins and advance EV proteomics toward clinical application in breast cancer management.
Objectives: Colorectal cancer (CRC) age-standardized mortality rates (ASMR) are increasing in the North Africa and Middle East (NAME) region, in contrast to the global trend. While the upward trend of the CRC mortality in the NAME region is evident, the key drivers of this increase are still not fully established. We sought to examine the impact of 11 risk factors on the rise in CRC mortality in the region. Methods: We obtained data from the Global Burden of Disease study 1990–2019. We examined changes in risk-related ASMR (ASMRΔ) for high body mass index (BMI), high fasting plasma glucose (FPG), low physical activity, smoking, alcohol, and six dietary factors. Analyses were stratified by sex. Rates and rate differences were expressed per 100 000. Results: CRC ASMR in the NAME region increased by 19.5% (ΔASMR = 1.6). ASMR increased by 25.0% (ΔASMR = 2.1) in men and 16.5% (ΔASMR = 1.3) in women. High FPG and high BMI had the highest risk-attributed ASMRΔ in the NAME population (0.56 and 0.55, respectively). In men, high BMI had the highest risk-attributed ΔASMR (0.85), while in women, high FPG had the highest risk-attributed ΔASMR (0.50). ΔASMR, related to all metabolic risks, (high FPG and high BMI) explained 64.4% of the CRC mortality increase in the region, 63.8% of the increase in men, and 53.8% of the increase in women. Conclusions: CRC mortality is increasing in the NAME region; hyperglycemia and obesity are the key drivers of the increasing trend. Interventions targeting metabolic risks are needed.
Oral and dental complications, including medication-related osteonecrosis of the jaw (MRONJ), are significant but often overlooked side effects of cancer t